Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wire-based antegrade dissection re-entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry.
Galassi AR, Vadalà G, Maniscalco L, Gasparini G, Jo D, Bozinovic NZ, Gorgulu S, Gehrig T, Grancini L, Ungi I, La Scala E, Ladwiniec A, Stojkovic S, La Manna A, Tumscitz C, Elhadad S, Werner GS, Sianos G, Garbo R, Carlino M, Mashayekhi K, di Mario C. Galassi AR, et al. Among authors: tumscitz c. Catheter Cardiovasc Interv. 2023 Nov;102(5):864-877. doi: 10.1002/ccd.30827. Epub 2023 Sep 5. Catheter Cardiovasc Interv. 2023. PMID: 37668012
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design.
Valgimigli M, Campo G, de Cesare N, Vranckx P, Hamon M, Angiolillo DJ, Sabatè M, Ferrari F, Furgieri A, Tumscitz C, Repetto A, Colangelo S, Meliga E, Kubbajeh M, Parrinello G, Percoco G, Ferrari R. Valgimigli M, et al. Among authors: tumscitz c. Cardiovasc Drugs Ther. 2008 Aug;22(4):313-20. doi: 10.1007/s10557-008-6121-z. Epub 2008 Jun 17. Cardiovasc Drugs Ther. 2008. PMID: 18561010 Clinical Trial.
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison.
Biscaglia S, Campo G, Tebaldi M, Tumscitz C, Pavasini R, Fileti L, Secco GG, Di Mario C, Ferrari R. Biscaglia S, et al. Among authors: tumscitz c. Int J Cardiovasc Imaging. 2016 Feb;32(2):211-223. doi: 10.1007/s10554-015-0756-1. Epub 2015 Sep 1. Int J Cardiovasc Imaging. 2016. PMID: 26323356
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction.
Tebaldi M, Biscaglia S, Erriquez A, Penzo C, Tumscitz C, Scoccia A, Quadri G, Sacchetta G, Folla A, Vadalà G, Fileti L, Campo G. Tebaldi M, et al. Among authors: tumscitz c. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):1057-1065. doi: 10.1002/ccd.29380. Epub 2020 Nov 19. Catheter Cardiovasc Interv. 2021. PMID: 33211381
Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry.
Valgimigli M, Saia F, Guastaroba P, Menozzi A, Magnavacchi P, Santarelli A, Passerini F, Sangiorgio P, Manari A, Tarantino F, Margheri M, Benassi A, Sangiorgi MG, Tondi S, Marzocchi A; REAL Registry Investigators. Valgimigli M, et al. JACC Cardiovasc Interv. 2012 Jan;5(1):23-35. doi: 10.1016/j.jcin.2011.08.018. JACC Cardiovasc Interv. 2012. PMID: 22230147 Free article.
59 results